Miracor Medical
Initiation and First Patient Enrolled in the PICSO-AMI-I Study
The first patient enrolled into this study was treated at Oxford Heart Center, Oxford, UK by Professor Adrian Banning, the principal investigator of the study.
Clinical Trials and Studies
PiCSO Therapy Reduces Infarct Size in STEMI Patients: Miracor Medical Announces New Publication at EuroPCR
Miracor Medical SA announced today the clinical results from the physician-sponsored OxAMI-PiCSO study were published in the EuroIntervention journal and presented at the Hotline session of the EuroPCR conference by Dr. Giovanni Luigi De Maria, MD, the...
